retatrutide phase 2 trial dosing schedule clinical retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Trial Data Dosing : – Retatrutide Dosing: Early Clinical Trial

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials

The inclusion of a 9mg dose tier is noteworthy because it was not tested in Phase 2

Storage guidelines differ between multi-dose pens and single-dose devices , and it's important to understand which type of device you're using

Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, et al

During power outages or refrigerator malfunctions, patients should contact their pharmacist or the medication manufacturer for guidance on temperature excursions

Change is on the horizon, though